Sumatriptan for the treatment of migraine attacks-a review of controlled clinical trials

Sumatriptan, a 5HT1-like receptor agonist, is a completely new treatment principle for migraine. In an extensive international programme of controlled clinical trials, sumatriptan, 6 mg subcutaneously and 100 mg orally, was superior to placebo in reducing headache and associated symptoms. The respon...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Tfelt-Hansen, Peer [verfasserIn]

Format:

E-Artikel

Erschienen:

USA/Oxford, UK: Blackwell Science Ltd ; 1993

Schlagwörter:

Controlled clinical trials

Umfang:

Online-Ressource

Reproduktion:

2002 ; Blackwell Publishing Journal Backfiles 1879-2005

Übergeordnetes Werk:

In: Cephalalgia - London [u.a.] : Sage, 1981, 13(1993), 4, Seite 0

Übergeordnetes Werk:

volume:13 ; year:1993 ; number:4 ; pages:0

Links:

Volltext

DOI / URN:

10.1046/j.1468-2982.1993.1304238.x

Katalog-ID:

NLEJ238586901

Nicht das Richtige dabei?

Schreiben Sie uns!